About: http://linked.opendata.cz/resource/sukl/spc/sentence/SPC128133

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://linked.opendata.cz/resource/sukl/spc/sentence/SPC128133_doc-4-8-146-1 Goto Sponge NotDistinct Permalink

An Entity of Type : salt:Sentence, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	salt:Sentence
salt:hasEndPointer	22298 (xsd:long)
salt:hasTextChunk	http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21908-21928 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21558-21568 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21576-21586 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21589-21599 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21625-21635 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21645-21655 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21658-21668 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21741-21747 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-21961-21966 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC128133_doc-4-8-146-1-22005-22011
salt:hasStartPointer	21528 (xsd:long)
salt:hasOrderNumber	1 (xsd:int)
salt:hasText	Nežádoucí účinky stupně 3 a 4 Paklitaxel versus gemcitabin + paklitaxel Počet (%) pacientů paklitaxel (N=259) gemcitabin + paklitaxel (N=262) stupeň 3 stupeň 4 stupeň 3 stupeň 4 Laboratorní anémie 5 (1,9) 1 (0,4) 15 (5,7) 3 (1,1) trombocytopenie 0 0 14 (5,3) 1 (0,4) neutropenie 11 (4,2) 17 (6,6)* 82 (31,3) 45 (17,2)* Nelaboratorní febrilní neutropenie 3 (1,2) 0 12 (4,6) 1 (0,4) únava 3 (1,2) 1 (0,4) 15 (5,7) 2 (0,8) průjem 5 (1,9) 0 8 (3,1) 0 motorická neuropatie 2 (0,8) 0 6 (2,3) 1 (0,4) senzorická neuropatie 9 (3,5) 0 14 (5,3) 1 (0,4) *neutropenie stupně 4 trvající déle než 7 dnů se projevila u 12,6 % pacientů ve skupině kombinované léčby a u 5 % pacientů ve skupině samotného paklitaxelu. (cs)
is salt:hasSentence of	http://linked.opendata.cz/resource/sukl/spc/paragraph/SPC128133_doc-4-8-146

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 96 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software